Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Kim Papp
Based on 54 articles published since 2009
(Why 54 articles?)
||||
Expertise Level
The expertise of Kim Papp ranks in the
  • Top 0.094%
  • ... of 37,126 published authors worldwide on Psoriasis
  • ... from 2009 through 2019
  • ... based on contributions to 54 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Miscellaneous institutions in Waterloo      
2019
  • 1 University of Toronto, ON, Canada. · 2 University Health Network, Toronto, ON, Canada. · 3 Probity Medical Research, Markham, ON, Canada. · 4 The Ottawa Hospital, ON, Canada. · 5 The University of Ottawa, ON, Canada. · 6 Probity Medical Research, Ottawa, ON, Canada. · 7 University of British Columbia, Vancouver, BC, Canada. · 8 BC Children's Hospital Research Institute, Vancouver, BC, Canada. · 9 Western University, London, ON, Canada. · 10 Memorial University of Newfoundland, St. John's, NL, Canada. · 11 Probity Medical Research, Waterloo, ON, Canada. · 12 University of Alberta, Edmonton, AB, Canada. · Pubmed 30742778
2018
  • University of Alabama at Birmingham School of Medicine, Birmingham, Alabama. Electronic address: · Fort Healthcare, Fort Atkinson, Wisconsin. · K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · Skin and Cancer Foundation Inc and Probity Medical Research, Carlton, Victoria, Australia. · Bakersfield Dermatology, Bakersfield, California. · Hopital La Miletrie, Service de Dermatologie, CHU Poitiers, Poitiers, France. · Janssen Scientific Affairs, Horsham, Pennsylvania. · Centre de Recherche Dermatologique du Québec Métropolitain, Québec City, Québec, Canada; Laval University, Québec City, Québec, Canada. · AbbVie Inc, North Chicago, Illinois. · Oregon Health and Science University Hospital, Portland, Oregon. · Pubmed 28993005
2017
  • Probity Medical Research, Waterloo, ON, Canada. Electronic address: · Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · CHU Sainte-Justine, Montreal, QC, Canada. · Paediatric Dermatology Department, University Children's Hospital and Dermatology Department, University Hospital Zurich, Zurich, Switzerland. · Charité University Medicine, Berlin, Germany. · UCL St Luc, Brussels, Belgium. · Nexus Clinical Research and Memorial University of Newfoundland, St John's, NL, Canada. · Department of Paediatric Dermatology, Catholic Children's Hospital, Hamburg, Germany. · AbbVie, North Chicago, IL, USA. · AbbVie Deutschland, Ludwigshafen, Germany. · Department of Dermatology and Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, Netherlands. · Pubmed 28478975
  • K Papp Clinical Research, Waterloo, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: · Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, Assistance Publique-Hopitaux de Paris Saint-Louis Hospital, Paris, France. · Dermatology Unit, Department of Neuroscience, Mental Health and Sensory Systems (NeSMOS) Department, Sapienza University of Rome, Rome, Italy. · Probity Medical Research, Carlton, Australia; Department of Medicine (Dermatology), University of Melbourne, St Vincent's Hospital Melbourne, Skin and Cancer Foundation Inc, Melbourne, Australia. · Probity Medical Research, Waterloo, Ontario, Canada; SKiN Centre for Dermatology, Peterborough, Ontario, Canada. · Amgen Inc, Thousand Oaks, California. · Dermoklinika Medical Centre, Lodz, Poland. · Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. · Probity Medical Research, Woolloongabba, Australia; Veracity Clinical Research, Woolloongabba, Australia. · Regional Hospital, Department of Dermatology, Wroclaw, Poland. · Probity Medical Research, Farmington, Connecticut; University of Connecticut Health Center, Connecticut. · Pubmed 28291552
  • Dermatologikum Hamburg and Georg-August-University, Göttingen, Germany. Electronic address: · Central Dermatology, St Louis, Missouri, USA. · K. Papp Clinical Research, Probity Medical Research, Waterloo, Ontario, Canada. · Department of Dermatology, New York Medical College, Valhalla, New York, USA. · Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 28780085
2016
  • Skin Centre for Dermatology, Peterborough, ON, Canada Probity Medical Research, Waterloo, ON, Canada · Skin Centre for Dermatology, Peterborough, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada Probity Medical Research, Waterloo, ON, Canada. · Pubmed 27207348
  • The Derm Centre, Winnipeg, MB, Canada · Oshawa Clinic, Oshawa, ON, Canada. · LEO Pharma A/S, Ballerup, Denmark. · K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · Pubmed 26224733
2015
  • Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada; Division of Dermatology, University of Toronto, Toronto, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 25807214
  • Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: · Dermatologikum Hamburg, Hamburg, Germany. · Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, Missouri. · Physicians Skin Care, PLLC, Louisville, Kentucky; Mount Sinai Medical Center, New York, New York. · University of Rome Tor Vergata, Rome, Italy. · Dalhousie University, Halifax, Nova Scotia, Canada. · Celgene Corporation, Summit, New Jersey. · Northwestern University, Chicago, Illinois. · University Hospitals Case Medical Center, Cleveland, Ohio. · Dermatology Center, Salford Royal Hospital, University of Manchester, Manchester, United Kingdom. · Pubmed 26089047
  • Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: · Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Dermatology, Radboud University Nijmegen, Nijmegen, Netherlands. · Department of Dermatology, Paul Sabatier University, Toulouse, France. · University of Texas, Southwestern Medical School, Dallas, TX, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Probity Medical Research, Waterloo, ON, Canada. · Pubmed 26072109
  • Probity Medical Research, Waterloo, Ontario, Canada. · Baylor University Medical Center, Dallas, Texas. · Probity Medical Research, Waterloo, Ontario, Canada; University of Connecticut School of Medicine, Farmington, Connecticut. · Amgen Inc, Thousand Oaks, California. · Amgen Inc, Thousand Oaks, California. Electronic address: · Pubmed 25553889
2014
  • Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: · Saint Louis University, Saint Louis, Missouri. · Baylor University Medical Center, Dallas, Texas. · Amgen Inc, Thousand Oaks, California. · Pubmed 25313095
2013
2012
2011
2010
  • Probity Medical Research Inc., Waterloo, Ontario, Canada. · Pubmed 20718590
  • K. Papp Clinical Research, Probity Medical Research, Waterloo, ON. · Pubmed 20642985
Probable:    Miscellaneous cities in Canada      
2018
  • Astellas Pharma, Inc., Northbrook, Illinois, USA. · K Papp Clinical Research and Probity Medical Research, Waterloo, Canada. · Astellas Pharma, Inc., Tokyo, Japan. · Auckland Clinical Studies Ltd, Auckland, New Zealand. · Pubmed 29679478
2016
  • a Faculty of Medicine , University of Toronto , Toronto , Canada. · b Skin Centre for Dermatology , Peterborough , Canada. · c Probity Medical Research , Waterloo , Canada. · d K. Papp clinical Research , Waterloo , Canada. · Pubmed 27690669
2011
Probable:    Queen's University      
2018
  • From K. Papp Clinical Research and Probity Medical Research, Waterloo (K.P.), the SKiN Centre for Dermatology and Probity Medical Research, Peterborough (M.G.), and Queen's University, Kingston (M.G.) - all in Ontario, Canada · Medical College of Wisconsin, Milwaukee (K.G.) · the University of Luebeck, Luebeck, Germany (D.T.) · Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan (A.M.) · the University of Melbourne, St. Vincent's Hospital Melbourne, Skin and Cancer Foundation, and Probity Medical Research, Melbourne, VIC, Australia (P.F.) · and Bristol-Myers Squibb, Princeton, NJ (I.G.G., S.K., S.B.). · Pubmed 30205746
2017
  • 1 Université de Montreal, Montreal, QC, Canada. · 2 Université de Sherbrooke, Quebec, QC, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 University of British Columbia, Surrey, BC, Canada. · 5 Memorial University of Newfoundland, St John's, NL, Canada. · 6 University of Toronto, Toronto, ON, Canada. · 7 Université de Laval, Quebec, QC, Canada. · 8 McMaster University, Hamilton, ON, Canada. · 9 University of Manitoba, Winnipeg, MB, Canada. · Pubmed 29156950
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 54 total) written by Kim Papp about Psoriasis:

  • Treating to Target(s) With Interleukin-17 Inhibitors. 2019
  • Clinical Trial and Registry Data. 2018
  • Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis. 2018
  • Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial. 2018
  • Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate-to-severe plaque psoriasis. 2018
  • Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial. 2017
  • Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study. 2017
  • Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition. 2017
  • Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis. 2017
  • An Open Letter to Health Canada. 2017
Show List of Full Article Records
Google Searches

Learn more about Kim Papp using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Waterloo
Miscellaneous cities in Canada
Queen's University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Waterloo
2019
  • 1 University of Toronto, ON, Canada. · 2 University Health Network, Toronto, ON, Canada. · 3 Probity Medical Research, Markham, ON, Canada. · 4 The Ottawa Hospital, ON, Canada. · 5 The University of Ottawa, ON, Canada. · 6 Probity Medical Research, Ottawa, ON, Canada. · 7 University of British Columbia, Vancouver, BC, Canada. · 8 BC Children's Hospital Research Institute, Vancouver, BC, Canada. · 9 Western University, London, ON, Canada. · 10 Memorial University of Newfoundland, St. John's, NL, Canada. · 11 Probity Medical Research, Waterloo, ON, Canada. · 12 University of Alberta, Edmonton, AB, Canada. · Pubmed 30742778
2018
  • University of Alabama at Birmingham School of Medicine, Birmingham, Alabama. Electronic address: · Fort Healthcare, Fort Atkinson, Wisconsin. · K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · Skin and Cancer Foundation Inc and Probity Medical Research, Carlton, Victoria, Australia. · Bakersfield Dermatology, Bakersfield, California. · Hopital La Miletrie, Service de Dermatologie, CHU Poitiers, Poitiers, France. · Janssen Scientific Affairs, Horsham, Pennsylvania. · Centre de Recherche Dermatologique du Québec Métropolitain, Québec City, Québec, Canada; Laval University, Québec City, Québec, Canada. · AbbVie Inc, North Chicago, Illinois. · Oregon Health and Science University Hospital, Portland, Oregon. · Pubmed 28993005
2017
  • Probity Medical Research, Waterloo, ON, Canada. Electronic address: · Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · CHU Sainte-Justine, Montreal, QC, Canada. · Paediatric Dermatology Department, University Children's Hospital and Dermatology Department, University Hospital Zurich, Zurich, Switzerland. · Charité University Medicine, Berlin, Germany. · UCL St Luc, Brussels, Belgium. · Nexus Clinical Research and Memorial University of Newfoundland, St John's, NL, Canada. · Department of Paediatric Dermatology, Catholic Children's Hospital, Hamburg, Germany. · AbbVie, North Chicago, IL, USA. · AbbVie Deutschland, Ludwigshafen, Germany. · Department of Dermatology and Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, Netherlands. · Pubmed 28478975
  • K Papp Clinical Research, Waterloo, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: · Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, Assistance Publique-Hopitaux de Paris Saint-Louis Hospital, Paris, France. · Dermatology Unit, Department of Neuroscience, Mental Health and Sensory Systems (NeSMOS) Department, Sapienza University of Rome, Rome, Italy. · Probity Medical Research, Carlton, Australia; Department of Medicine (Dermatology), University of Melbourne, St Vincent's Hospital Melbourne, Skin and Cancer Foundation Inc, Melbourne, Australia. · Probity Medical Research, Waterloo, Ontario, Canada; SKiN Centre for Dermatology, Peterborough, Ontario, Canada. · Amgen Inc, Thousand Oaks, California. · Dermoklinika Medical Centre, Lodz, Poland. · Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. · Probity Medical Research, Woolloongabba, Australia; Veracity Clinical Research, Woolloongabba, Australia. · Regional Hospital, Department of Dermatology, Wroclaw, Poland. · Probity Medical Research, Farmington, Connecticut; University of Connecticut Health Center, Connecticut. · Pubmed 28291552
  • Dermatologikum Hamburg and Georg-August-University, Göttingen, Germany. Electronic address: · Central Dermatology, St Louis, Missouri, USA. · K. Papp Clinical Research, Probity Medical Research, Waterloo, Ontario, Canada. · Department of Dermatology, New York Medical College, Valhalla, New York, USA. · Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 28780085
2016
  • Skin Centre for Dermatology, Peterborough, ON, Canada Probity Medical Research, Waterloo, ON, Canada · Skin Centre for Dermatology, Peterborough, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada Probity Medical Research, Waterloo, ON, Canada. · Pubmed 27207348
  • The Derm Centre, Winnipeg, MB, Canada · Oshawa Clinic, Oshawa, ON, Canada. · LEO Pharma A/S, Ballerup, Denmark. · K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · Pubmed 26224733
2015
  • Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada; Division of Dermatology, University of Toronto, Toronto, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 25807214
  • Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: · Dermatologikum Hamburg, Hamburg, Germany. · Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, Missouri. · Physicians Skin Care, PLLC, Louisville, Kentucky; Mount Sinai Medical Center, New York, New York. · University of Rome Tor Vergata, Rome, Italy. · Dalhousie University, Halifax, Nova Scotia, Canada. · Celgene Corporation, Summit, New Jersey. · Northwestern University, Chicago, Illinois. · University Hospitals Case Medical Center, Cleveland, Ohio. · Dermatology Center, Salford Royal Hospital, University of Manchester, Manchester, United Kingdom. · Pubmed 26089047
  • Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: · Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Department of Dermatology, Radboud University Nijmegen, Nijmegen, Netherlands. · Department of Dermatology, Paul Sabatier University, Toulouse, France. · University of Texas, Southwestern Medical School, Dallas, TX, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Probity Medical Research, Waterloo, ON, Canada. · Pubmed 26072109
  • Probity Medical Research, Waterloo, Ontario, Canada. · Baylor University Medical Center, Dallas, Texas. · Probity Medical Research, Waterloo, Ontario, Canada; University of Connecticut School of Medicine, Farmington, Connecticut. · Amgen Inc, Thousand Oaks, California. · Amgen Inc, Thousand Oaks, California. Electronic address: · Pubmed 25553889
2014
  • Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: · Saint Louis University, Saint Louis, Missouri. · Baylor University Medical Center, Dallas, Texas. · Amgen Inc, Thousand Oaks, California. · Pubmed 25313095
2013
2012
2011
2010
  • Probity Medical Research Inc., Waterloo, Ontario, Canada. · Pubmed 20718590
  • K. Papp Clinical Research, Probity Medical Research, Waterloo, ON. · Pubmed 20642985
Miscellaneous cities in Canada
2018
  • Astellas Pharma, Inc., Northbrook, Illinois, USA. · K Papp Clinical Research and Probity Medical Research, Waterloo, Canada. · Astellas Pharma, Inc., Tokyo, Japan. · Auckland Clinical Studies Ltd, Auckland, New Zealand. · Pubmed 29679478
2016
  • a Faculty of Medicine , University of Toronto , Toronto , Canada. · b Skin Centre for Dermatology , Peterborough , Canada. · c Probity Medical Research , Waterloo , Canada. · d K. Papp clinical Research , Waterloo , Canada. · Pubmed 27690669
2011
Queen's University
2018
  • From K. Papp Clinical Research and Probity Medical Research, Waterloo (K.P.), the SKiN Centre for Dermatology and Probity Medical Research, Peterborough (M.G.), and Queen's University, Kingston (M.G.) - all in Ontario, Canada · Medical College of Wisconsin, Milwaukee (K.G.) · the University of Luebeck, Luebeck, Germany (D.T.) · Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan (A.M.) · the University of Melbourne, St. Vincent's Hospital Melbourne, Skin and Cancer Foundation, and Probity Medical Research, Melbourne, VIC, Australia (P.F.) · and Bristol-Myers Squibb, Princeton, NJ (I.G.G., S.K., S.B.). · Pubmed 30205746
2017
  • 1 Université de Montreal, Montreal, QC, Canada. · 2 Université de Sherbrooke, Quebec, QC, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 University of British Columbia, Surrey, BC, Canada. · 5 Memorial University of Newfoundland, St John's, NL, Canada. · 6 University of Toronto, Toronto, ON, Canada. · 7 Université de Laval, Quebec, QC, Canada. · 8 McMaster University, Hamilton, ON, Canada. · 9 University of Manitoba, Winnipeg, MB, Canada. · Pubmed 29156950
Dalhousie University
2015
  • From the Icahn School of Medicine at Mount Sinai, New York (M.L., L.K.) · University of Connecticut School of Medicine, Farmington (B.S.) · Probity Medical Research (B.S., L.S., D.T.) and XLR8 Medical Research (D.T.), Windsor, ON, K Papp Medical Research (K.P.), Waterloo, ON, and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada · Baylor University Medical Center, Dallas (A.M.) · Northwestern University, Feinberg School of Medicine, Chicago (K.G.) · Niepubliczny Zakład Opieki Zdrowotnej multiMedica, Wrocław (J.W.), and Lubelskie Centrum Diagnostyczne, Świdnik (T.B.) - both in Poland · Hospital de la Santa Creu i Sant Pau, Barcelona (L.P.) · Veracity Clinical Research, Woolloongabba, QLD, Australia (L.S.) · Florida Academic Dermatology Center, Miami (F.K.) · University of Colorado, Denver (A.W.A.) · Medizinische Universität Wien, Vienna, Austria (G.S.) · Massachusetts General Hospital and Harvard Medical School, Boston (A.B.K.) · Sorbonne Paris Cité Université Paris Diderot, Assistance Publique-Hôpitaux de Paris Hôpital Saint Louis, Paris (H.B.), Paul Sabatier University, Toulouse (C.P.), and University Hospital of Nice, Nice (J.-P.L.) - all in France · Kaiser Permanente Los Angeles Medical Center, Los Angeles (J.J.W.), Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield (J.C.), University of California, San Francisco, San Francisco (J.K.), and Amgen, Thousand Oaks (G.A., J.L., W.S., C.E.M., Y.S., N.E., P.K., B.K., A.N.) - all in California. · University of Texas Health Science Center, Houston (S.T.) · DermResearch, Louisville, KY (L.K.) · University of Rome Tor Vergata, Rome (S.C.) · University of Utah Medical Center, Salt Lake City (K.C.D.) · and the Psoriasis Treatment Center of Central New Jersey, East Windsor (J.B.). · Pubmed 26422722
2014
  • From Dalhousie University, Halifax, NS (R.G.L.), Clinical Research (K.P.) and Probity Medical Research (K.P., L.S.), Waterloo, ON, and Stratica Medical and Probity Medical Research, Edmonton, AB (N.W.) - all in Canada · University of Alabama, Birmingham (B.E.E.) · Mount Sinai Hospital, New York (M.L.) · Dermatologikum Hamburg and Georg-August-Universität, Göttingen, Germany (K.R.) · Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom (C.E.M.G.) · Hospital de Sant Pau, Barcelona (L.P.) · Jikei University School of Medicine, Tokyo (H.N.) · Veracity Clinical Research, Woolloongabba, QLD, Australia (L.S.) · Faculty of Medicine, Department of Dermatology, University of Iceland, Reykjavik (B.S.) · Dermos, Guatemala City, Guatemala (E.R.) · Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei (T.-F.T.) · University of Texas Health Science Center and Center for Clinical Studies, Houston (S.T.) · and Novartis Pharma, Basel, Switzerland (T.S., I.H., M.N., A.K., S.H., C.P.). · Pubmed 25007392
2011
2010
  • Department of Medicine, Dalhousie University, Halifax, NS. · Pubmed 20618506
University of Western Ontario
2009
  • Probity Medical Research, University of Western Ontario, Waterloo, ON. · Pubmed 19799828
13 Other Locations Show
Yearly article counts 14637235788
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.